Related Examinations

The first visit is usually to the Department of Breast Surgery. If there is distant metastasis, it is usually to the Internal Medicine Department of Oncology or the Internal Medicine Department of Breast.

Physical examination

It is used for the initial screening of breast cancer to determine whether the patient has abnormal breast signs (such as breast lumps, breast skin changes, nipple discharge, etc.), as well as the condition of lymph nodes. Later, it needs to be diagnosed in combination with other auxiliary examination results.

Imaging examination

Breast molybdenum target

It is widely used in the screening of breast cancer. Its advantage is to see calcification foci, especially some small calcification foci (which may be the manifestation of very early breast cancer).

Breast ultrasound

It is used for the diagnosis and differential diagnosis of breast cancer and can judge the nature of the lump. It can be used as the preferred imaging examination for young, pregnant, and lactating women.

Breast MRI

Breast MRI is used for the staging assessment of breast cancer. It has advantages in finding small lesions, multicenters, and multifocal lesions, and evaluating the range of lesions.

Tissue biopsy

For patients with suspected breast cancer, but imaging can’t show a clear result, the tumor can be removed together with the surrounding breast tissue for histopathological examination.

In addition to direct resection, the tumor can be punctured under ultrasound guidance to remove a small amount of tumor tissue for pathological examination.

Breast cancer tumor marker examination

Common examination indicators include CA15-3, CEA, CA125, etc., which provide a supplementary basis for the diagnosis of breast cancer and monitor postoperative recurrence and metastasis.

Immunohistochemistry examination

Common examination indicators include Ki-67, HER-2, ER, PR, etc., which are used to confirm the molecular type of breast cancer and provide a basis for later treatment. Positive ER and PR indicate hormone-dependent breast cancer, while positive Ki-67 and HER-2 indicate that the tumor is highly invasive and prone to recurrence and metastasis.